{"cluster": 48, "subcluster": 91, "abstract_summ": "To identify the key laboratory indicators and stratify high-risk COVID-19 patients with progression to severe/critical illness, we compared 474 moderate patients and 74 severe/critical patients.Conclusions The most important laboratory abnormalities described here in a subset of European COVID-19 patients residing in Valcamonica are highly predictive of in-hospital death and may be useful for guiding risk assessment and clinical decision-making.Conclusion: Laboratory markers of inflammation and coagulopathy can help clinicians identify patients who are at high risk for clinical deterioration, independent of clinically significant medical comorbiditiesThe high mortality rate of COVID-19 patients is mainly caused by the progression from mild to critical illness.Objective: To describe the association between D-dimer, CRP, IL-6, ferritin, LDH, and clinical outcomes in a cohort of COVID-19 patients treated on the inpatient medical service at a university hospital in Washington, DC.The patients with lower risk had better prognosis than patients with higher risk.", "title_summ": "The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. CohortLaboratory Testing Implications of Risk-Stratification and Management for Improving Clinical Outcomes of COVID-19 PatientsIdentification of a metabolic gene panel to predict the prognosis of myelodysplastic syndromeLaboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.", "title_abstract_phrases": "Conclusion: Laboratory markers of inflammation and coagulopathy can help clinicians identify patients who are at high risk for clinical deterioration, independent of clinically significant medical comorbiditiesLaboratory Testing Implications of Risk-Stratification and Management for Improving Clinical Outcomes of COVID-19 PatientsThe high mortality rate of COVID-19 patients is mainly caused by the progression from mild to critical illness.To identify the key laboratory indicators and stratify high-risk COVID-19 patients with progression to severe/critical illness, we compared 474 moderate patients and 74 severe/critical patients.Conclusions The most important laboratory abnormalities described here in a subset of European COVID-19 patients residing in Valcamonica are highly predictive of in-hospital death and may be useful for guiding risk assessment and clinical decision-making.Objective: To describe the association between D-dimer, CRP, IL-6, ferritin, LDH, and clinical outcomes in a cohort of COVID-19 patients treated on the inpatient medical service at a university hospital in Washington, DC.The patients with lower risk had better prognosis than patients with higher risk."}